Puma Biotechnology, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2018
Total Assets: $259.1M
Liabilities Breakdown FY2018
Total Liabilities: $224.8M
Asset Breakdown
Total Assets: $259.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $108.4M | 41.8% |
| Accounts Receivable | $20.8M | 8.0% |
| Inventory | $2.6M | 1.0% |
| Property, Plant & Equipment | $4.0M | 1.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $44.4M | 17.1% |
| Other Assets | $78.9M | 30.5% |
Liabilities Breakdown
Total Liabilities: $224.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $20.7M | 9.2% |
| Long-Term Debt | $151.9M | 67.6% |
| Other Liabilities | $52.2M | 23.2% |